S-Homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia

Biochemical and Biophysical Research Communications

Volumn 310, Issue 1, 2003, Pages 242-246

  Sass, Jörn Oliver ^a   Nakanishi, Toyofumi ^b   Sato, Takako ^b   Sperl, Wolfgang ^c   Shimizu, Akira ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c St Johanns Spital   (Austria)

Author keywords

Cobalamin; Folate; High pressure liquid chromatography electrospray ionization mass spectrometry; Homocysteine; Homocysteine thiolactone; Homocysteinylation; Lysine; Transthyretin; Vitamin B12

Indexed keywords

HOMOCYSTEINE; PREALBUMIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HYPERHOMOCYSTEINEMIA; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 0141497435     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.089     Document Type: Article

References (27)

1. Mudd S.H., Levy L.H., Kraus J.P. Disorders of transulfuration. Scriver C., Beaudet A.L., Sly W.S., Valle D. eighth ed. The Metabolic and Molecular Bases of Inherited Disease. vol. II:2001;2007-2056 McGraw-Hill, New York.
2. Rosenblatt D., Fenton W.A. Inherited disorders of folate and cobalamin transport and metabolism. Scriver C., Beaudet A.L., Sly W.S., Valle D. eighth ed. The Metabolic and Molecular Bases of Inherited Disease. vol. II:2001;3897-3933 McGraw-Hill, New York.
3. Medina M.Á., Urdiales J.L., Amores-Sánchez M.I. Roles of homocysteine in cell metabolism-old and new functions. Eur. J. Biochem. 268:2001;3871-3882.
4. Herrmann W. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin. Chem. Lab. Med. 39:2001;666-674.
5. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures: possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 272:1997;1935-1941.
6. Ferguson E., Parthasarathy S., Joseph J., Kalyanaraman B. Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoprotein. J. Lipid Res. 39:1998;925-933.
7. Jakubowski H. Aminoacylation of coenzyme A and pantetheine by aminoacyl-tRNA synthetases: possible link between non-coded and coded peptide synthesis. Biochemistry. 37:1998;5147-5153.
8. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 13:1999;2277-2283.
9. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J. Nutr. 130(Suppl.):2000;377-381.
10. Jakubowski H. Translational incorporation of S-nitroso-homocysteine into protein. J. Biol. Chem. 275:2000;21813-21816.
11. Jakubowski H., Zhang L., Bardeguez A., Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ. Res. 87:2000;45-51.
12. Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase: a protective mechanism against protein N-homocysteinylation. J. Biol. Chem. 275:2000;3957-3962.
13. Jakubowski H., Ambrosius W., Pratt J.H. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis. FEBS Lett. 491:2001;35-39.
14. Jakubowski H. Translational accuracy of aminoacyl-tRNA synthetases: implication for atherosclerosis. J. Nutr. 131(Suppl.):2001;2983-2987.
15. Jakubowski H. Protein N-homocysteinylation: implications for atherosclerosis. Biomed. Pharmacother. 55:2001;443-447.
16. Jakubowski H. Homocysteine is a protein amino acid in humans: implications for homocysteine-linked disease. J. Biol. Chem. 277:2002;30425-30428.
17. Hop C.E.C.A., Bakhtiar R. Homocysteine thiolactone and protein homocysteinylation: mechanistic studies with model peptides and proteins: mechanistic studies with model peptides and proteins. Rapid. Commun. Mass Spectrom. 16:2002;1049-1053.
18. Schreiber G. Beyond carrier proteins - the evolutionary and integrative roles of transthyretin in thyroid hormone homeostasis. J. Endocrinol. 175:2002;61-73.
19. Kishikawa M., Nakanishi T., Miyazaki A., Shimizu A. A simple and reliable method of detecting variant transthyretins by multidimensional liquid chromatography coupled to electrospray ionization mass spectrometry. Amyloid. 6:1999;48-53.
20. Saraiva M.J. Recent advances in the molecular pathology of familial amyloid polyneuropathy. Neuromuscul. Disord. 1:1991;3-6.
21. Saraiva M.J. Transthyretin mutations in health and disease. Hum. Mutat. 5:1995;191-196.
22. Wada Y., Matsuo T., Katakuse I., Suzuki T., Azuma T., Tsujino S., Kishimoto S., Matsuda H., Hayashi A. Mass spectrometric detection of the plasma prealbumin (transthyretin) variant associated with familial amyloidotic polyneuropathy. Biochim. Biophys. Acta. 873:1986;316-319.
23. Suzuki T., Azuma T., Tsujino S., Mizuno R., Kishimoto S., Wada Y., Hayashi A., Ikeda S., Yanagisawa N. Diagnosis of familial amyloidotic polyneuropathy: isolation of variant prealbumin. Neurology. 37:1987;708-711.
24. Kishikawa M., Nakanishi T., Shimizu A., Yoshino M. Detection by mass spectrometry of highly increased amount of S-sulfonated transthyretin in serum from a patient with molybdenum cofactor deficiency. Pediatr. Res. 47:2000;492-494.
25. Kishikawa M., Sass J.O., Sakura N., Nakanishi T., Shimizu A., Yoshioka M. The peak height ratio of S-sulfonated transthyretin and other oxidized isoforms as a marker for molybdenum cofactor deficiency, measured by electrospray ionization mass spectrometry. Biochim. Biophys. Acta. 1588:2002;135-138.
26. 1c measurement based on peptide analysis by electrospray ionization mass spectrometry with deuterium-labeled synthetic peptides as internal standards. Clin. Chem. 49:2003;829-831.
27. Majors A.K., Sengupta S., Willard B., Kinter M.T., Pyeritz R.E., Jacobsen D.W. Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler. Thromb. Vasc. Biol. 22:2002;1354-1359.